경희대학교 의과대학·의학전문대학원

21  Download (0)

Full text
(1)

Blood Coagulation Tests

Lee Woo In, MD, PhD

Department of Laboratory Medicine

(2)

Homeostasis ( 항상성 )

Procoagulant

Regulatory

Endothelium

(3)

NL Endothelial Cell

NL Endothelial Cell :

Anti-thrombotic state

- 항혈소판

,

- 항응고

,

- 섬유소용해

Damaged Vessel :

Damaged Vessel :

Thrombotic state

-Platelet activation

-Adhesion

-Prothrombotic

(4)

Primary Hemostasis

Primary Hemostasis

Platelet plug :key

Platelet plug :

혈관수축

혈소판

adhesion,

aggregation

작은 혈관손상의 지혈

Function of platelet

– Adhesion

– Release

– Aggregation

– Coagulant activity

(5)

Secondary Hemostasis

Secondary Hemostasis

Fibrin clot :key

응고인자 활성화

큰 혈관손상

(6)

Three factors for Hemostasis

Three factors for Hemostasis

• Vascular factors

– local vasoconstriction (immediate reaction)

– compression of injured vessels by blood

extravasated into surrounding tissues

• Platelet factors

– adhere to the site & form aggregates

(

hemostatic plugs

)

– release factors to augment vasoconstriction

– vessel wall repair (platelet-derived growth

factor)

(7)

Plasma Coagulation factors

• Factor I: fibrinogen

• Factor II: prothrombin

• Factor III: tissue thromboplastin (tissue factor & phospholipid) • Factor IV: ionized calcium

• Factor V: occasionally called labile factor or proaccelerin • Factor VI: unassigned

• Factor VII: occasionally called stable factor or proconvertin • Factor VIII: anti-hemophilic factor

• Factor IX: plasma thromboplastin component, Christmas factor • Factor X: occasionally called Stuart-Prower factor

• Factor XI: occasionally called plasma thromboplastin antecedent

• Factor XII: Hageman factor

(8)

Coagulation Cascade

E x tr in s ic p a th w a y In tr in s ic p a th w a y

(9)

Regulatory mechanisms

• Normally prevent activated

coagulation reactions

– local thrombosis or DIC

• Antithrombin III, protein C, protein S,

etc

• Fibrinolytic system

• Plasmin-plasminogen system

• etc

(10)

Coagulation Tests

Coagulation Tests

Tests for Hemostatic plug(Primary hemostasis)

1. Bleeding time

Vessel contraction & primary hemostasis 혈소판질환, 폰빌레브란트 병

2. Platelet count

3. Platelet function test

(11)

2) Aggregation test

; ADP, collagen,

thrombin, epinephrine,

ristocetin

 응집률 , 속도

3) 혈소판 기능과

아스피린 저항성 검사

(12)

Tests for fibrin plug (2ndary hemostasis)

1. Prothrombin time(PT)

환자혈장

+ tissue thromboplastin + 칼슘

Factor VII activation Fibrin clot 시간 측정

I, II, V, VII, X 인자 (NL 30% 이어도 PT 정상 )

Report 단위 : sec, %, INR

• INR : Vit K dependent factor(II, VII, IX, X) 길항제인 coumarin(warfarin) 복용 환자의 치료 농도

monitoring 에 이용

• INR(international normalized ratio)= ( 환자의 PT/ 참고치 PT)ISI (internaltional sensitivity index)

(13)

2. aPTT

– Factor XII, XI 응고인자에 대한 활성제 (kaolin,

ellagic acid, celite), 혈소판 대용 물질인 인지질 첨가

– VIII, IX, X,

XII, prekallikrein, HMWK

• I, II, V, X 은 공통 이나 문제 발생하면 PT 가 연장

– 헤파린

• 오염 • 헤파린 치료 ( 정상 aPTT 의 1.5 ~ 2.5 배 ) – LMWH, 헤파린유사 항응고제 등은 anti-Xa 법으로 검사

– lupus anticoagulant

3. Mixing test( 혈장혼합검사 )

– 감별 : 응고인자 결핍 vs. 응고억제인자

– 정상범위로 교정되면

• 응고인자 억제인자 , anti-phospholipid ab.,anti-prothrombin

(14)

4. Activated clotting time(ACT)

– aPTT 와 유사 , , 헤파린 치료 모니터링

5. Thrombin time

– Hypofibrinogenemia, 섬유소기능이상 , 과섬유소원증 , 섬유소 로 전환되는 것을 억제하는 인자 여부 ( 헤파린 , FDP)

6. Fibrinogen

– Acute phase reactant

– DIC, 간질환 , 혈전용해치료 등에서 증가

7. Coagulation factor assay

8. von Willebrand factor

subendothelial cell, megakaryocyte 에서 생성되어 platelet adhesion

- factor VIII 과 복합체를 이루며 순환

- Ristocetin cofactor assay … vWF 의 기능 검사 - Ristocetin 에 의한 혈소판응집정도

(15)

Laboratory markers of Fibrinolysis

Laboratory markers of Fibrinolysis

• Fibrinolysis

– Fibrin clot 이 다시 용해되는 과정

– Key : plasmin

(16)
(17)

FDP test ( fibrinogen/fibrin degradation product) ; 섬유소용해 선별검사 DIC screening, hyperfibrinolysis, thromboembolic disease 증가 D-dimer fibrin clot 이 있었음을 의미 섬유소용해 확진 검사 (-): thrombosis 진단을 배제 Plasminogen Alpha-2 antiplasmin

(18)

Acquired inhibitor

• VIII 응고인자 항체

• VIII 응고인자 일정량을 불활성화 시키는 inhibitor activity

• Pt plasma + Normal plasma residual activity of factor VIII 측정

• 1 Bethesda unit: 1mL 내의 응고억제인자가 응고인자 VIII 활성도를 50% 로 감소시키는 양

• Lupus anticoagulant

– 항인지질 항체 (antiphospholipid antibody, APA) 의 일종 – 자가면역성 , 동종면역성 면역글로블린

• Antiphospholipid Antibody

– SLE, autoimmune disease, lymphoprolierative disease

(19)

Natural Anticoagulants

• Anti-thrombin

– Factor Xa, thrombin 억제

– Heparin 에 의해 활성도 증가

– 유전 , 간질환 ,DIC,oral contraceptive, preeclampsia

• Protein C

– Thrombin 에 의해 활성화 , factor Va, VIIIa 을 억제

• Protein S

– Protein C 의 coenzyme

 -2 macroglobulin, heparin cofactor II

(20)

Tests for Hypercoagulation states

1. 유전성 혈전성향의 원인

Natural anticoagulant 기능소실 응고인자의 기능항진

2. 복합적 요인에 의한 과응고 상태

3. 후천적 과응고 상태

Tests

Primary antithrombin activity C protein activity

S protein antigen

activated protein C resistance Lupus anticoagulant

Anticardiolipin Ab Secondary Leiden V 인자

prothrombin G20210A

(21)

Figure

Updating...

References

Related subjects :

Install 1PDF app in